Skip to main content

Table 1 Baseline characteristics of study subjects

From: Pattern and predictors of immunologic recovery in HIV infected patients

 

Health institution, n (%)

KATH

SGH

Total

Gender Female

67 (67.0 %)

92 (80.7)

159 (74.3)

Age (median, IQR)

38 (33–45)

35 (31–42)

37 (32–43)

Educational levels

 None

16 (19.0)

0 (0.0)

16 (8.1)

 Primary

49 (58.3)

77 (67.5)

126 (63.6)

 Secondary

11 (13.1)

7 (6.1)

18 (9.1)

 Tertiary

8 (9.5)

30 (26.3)

38 (19.2)

Economic status

 Low

71 (86.6)

86 (75.4)

157 (80.1)

 Medium

10 (12.2)

22 (19.3)

32 (16.3)

 High

1 (1.2)

6 (5.3)

7 (3.6)

Primary caregiver

 Spouse

21 (25)

43 (37.7)

64 (32.3)

 Relatives

34 (40.5)

57 (50)

91 (46)

 Self

25 (29.8)

4 (3.5)

29 (14.6)

 Others

4 (4.8)

10 (8.8)

14 (7.1)

Drug

 Azidovudine/lamivudine + NNRTI

39 (50.6)

21 (18.4)

60 (31.4)

 Azidovudine/lamivudine + PI

0 (0)

18 (15.8)

18 (9.4)

 Stavudine/lamivudine + NNRTI

21 (27.3)

74 (64.9)

95 (49.7)

 Others

17 (22.1)

1 (0.9)

18 (9.4)